NIH supports basic research on how toxic chemicals injure skin to spur discovery and early development of broad-spectrum medical countermeasures; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: November 5, 2026 (Renewal / Resubmission / Revision) | October 5, 2027 (New) | November 5, 2027 (Renewal / Resubmission / Revision) | October 5, 2028 (New) | November 5, 2028 (Renewal / Resubmission / Revision; final closing)
Funding Amounts: Up to $300,000 per year in direct costs for up to 5 years; 5 awards expected
Summary: Supports basic research on mechanisms of chemical-induced skin injury to identify targets for broad-spectrum medical countermeasures.
Key Information: Research must address skin injury after a single acute exposure to a U.S. Government Chemical of Concern; clinical trials are not allowed.
This NIH R01 initiative supports basic research into the pathological mechanisms of skin injuries caused by toxic Chemicals of Concern (CoCs) identified as public health threats by the U.S. Government. Participating institutes are NIAMS, NIAID, and NIDA through the trans-NIH Chemical Countermeasures Research Program (CCRP). The program seeks discoveries that advance medical and public health preparedness for, response to, and recovery from high-consequence chemical emergencies.
Projects should investigate molecular, cellular, and immunological processes underlying chemical skin injury and identify therapeutic targets supporting skin healing. Investigators are encouraged to explore shared targets across different CoCs, including signaling pathways and inflammatory processes, to enable broadly effective countermeasures. The focus is injury following a single acute exposure, rather than chronic exposure. Researchers experienced in cutaneous wound healing are encouraged to apply.